Selected Publications
Bernabei, Luca, Tian, Lifeng, Garfall, Alfred L, Melenhorst, J Joseph, Lacey, Simon F, Stadtmauer, Edward A, Vogl, Dan T, Gonzalez, Vanessa E, Plesa, Gabriela, Young, Regina M, Waxman, Adam, Levine, Bruce L, June, Carl H, Milone, Michael C, Cohen, Adam D: B-cell maturation antigen chimeric antigen receptor T-cell re-expansion in a patient with myeloma following salvage programmed cell death protein 1 inhibitor-based combination therapy. British Journal of Haematology : 2021.
Lazarow, Heather, Singer, Ryan, Compher, Charlene, Gilmar, Cheryl, Kucharczuk, Colleen R, Mangan, Patricia, Salam, Kelly, Cunningham, Kathleen, Stadtmauer, Edward A, Landsburg, Daniel J: Effect of malnutrition-driven nutritional support protocol on clinical outcomes in autologous stem cell transplantation patients. Supportive Care in Cancer : 2021.
Chari, Ajai, Samur, Mehmet Kemal, Martinez-Lopez, Joaquin, Cook, Gordon, Biran, Noa, Yong, Kwee, Hungria, Vania, Engelhardt, Monika, Gay, Francesca, Garcia Feria, Ana, Oliva, Stefania, Oostvogels, Rimke, Gozzetti, Alessandro, Rosenbaum, Cara, Kumar, Shaji, Stadtmauer, Edward A, Einsele, Hermann, Beksac, Meral, Weisel, Katja, Anderson, Kenneth C, Mateos, Maria-Victoria, Moreau, Philippe, San-Miguel, Jesus, Munshi, Nikhil C, Avet-Loiseau, Herve: Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set. Blood : 2020.
Costa, Luciano J, Iacobelli, Simona, Pasquini, Marcelo C, Modi, Riddhi, Giaccone, Luisa, Blade, Joan, Schonland, Stefan, Evangelista, Andrea, Perez-Simon, Jose A, Hari, Parameswaran, Brown, Elizabeth E, Giralt, Sergio A, Patriarca, Francesca, Stadtmauer, Edward A, Rosinol, Laura, Krishnan, Amrita Y, Gahrton, Gosta, Bruno, Benedetto: Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation. Bone Marrow Transplantation : 2020.
Frey NV, Gill S, Hexner EO, Schuster S, Nasta S, Loren A, Svoboda J, Stadtmauer E, Landsburg DJ, Mato A, Levine BL, Lacey SF, Melenhorst JJ, Veloso E, Gaymon A, Pequignot E, Shan X, Hwang WT, June CH, Porter DL: Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia Journal of Clinical Oncology : 2020.
Foss, Francine M, Wang, Xin Victoria, Luger, Selina M, Jegede, Opeyemi, Miller, Kenneth B, Stadtmauer, Edward A, Whiteside, Theresa L, Avigan, David E, Gascoyne, Randall D, Arber, Daniel, Wagner, Henry, Strair, Roger K, Hogan, William J, Sprague, Kellie A, Lazarus, Hillard M, Litzow, Mark R, Tallman, Martin S, Horning, Sandra J: Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902. Transfusion : 2020.
Kim, Gee Youn Geeny; Burns, Jonathan; Freyer, Craig W; Hamilton, Keith W; Frey, Noelle V; Gill, Saar I; Hexner, Elizabeth O; Luger, Selina M; Mangan, James K; Martin, Mary E; McCurdy, Shannon R; Perl, Alexander E; Porter, David L; Schuster, Mindy G; Stadtmauer, Edward A; Loren, Alison W.: Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents. American Journal of Hematology : 2020.
Giralt S, Costa LJ, Maloney D, Krishnan A, Fei M, Antin JH, Brunstein C, Geller N, Goodman S, Hari P, Logan B, Lowsky R, Qazilbash MH, Sahebi F, Somlo G, Rowley S, Vogl DT, Vesole DH, Pasquini M, Stadtmauer E: Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 Trial. Biol Blood Marrow Transplant : 2020.
Kim GYG, Burns J, Freyer CW, Hamilton KW, Frey NV, Gill SI, Hexner EO, Luger SM, Mangan JK, Martin ME, McCurdy SR, Perl AE, Porter DL, Schuster MG, Stadtmauer EA, Loren AW: Risk of Invasive fungal infections in patients with high-rish MDS and AML recieving hypomethylating agents American Journal of Hematology : 2020.
Stadtmauer EA, Fraietta JA, Davis MM, Cohen AD, Weber KL, Lancaster E, Mangan PA, Kulikovskaya I, Gupta M, Chen F, Tian L, Gonzalez VE, Xu J, Jung IY, Melenhorst JJ, Plesa G, Shea J, Matlawski T, Cervini A, Gaymon AL, Desjardins S, Lamontagne A, Salas-Mckee J, Fesnak A, Siegel DL, Levine BL, Jadlowsky JK, Young RM, Chew A, Hwang WT, Hexner EO, Carreno BM, Nobles CL, Bushman FD, Parker KR, Qi Y, Satpathy AT, Chang HY, Zhao Y, Lacey SF, June CH: CRISPR-engineered T cells in patients with refractory cancer Science : 2020.
Academic Contact Information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-171
3400 Civic Center Blvd
Philadelphia,
PA
19104
Phone: 215-662-7910
Patient appointments: 800-789-7366